Chicago, ILNCT07041775Now EnrollingIRB Ready

Stroke Clinical Trial in Chicago, IL

Access cutting-edge stroke treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Northwestern University

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access stroke specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related stroke treatment provided free

Apply for This Chicago Location

Check if you qualify for this stroke clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Stroke Study in Chicago

This study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.

Sponsor: Northwestern University

Who Can Participate

Inclusion Criteria

Age at enrollment is 18 to 85
Leg impairment from unilateral stroke at least 6 months prior to screening
Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed)
Able to stand without assistance
Clinically observable gait asymmetry
Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5)

Exclusion Criteria

Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task
Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games
Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games
Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment
Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training
Diffuse or multifocal infarcts
Substantial leg or other pain preventing participation for 60 minutes a day
Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months
Severe osteoporosis causing hip or other fractures
History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in the first session.
Contracture limiting the range of motion of the leg
Current pregnancy
From the TMS portion of the study only: History of epilepsy in adulthood requiring antiseizure medications; recent/current alcoholism or benzodiazepine/barbiturate abuse or recent history of alcohol/benzodiazepine/barbiturate withdrawal, recent history of cocaine or amphetamine use, skull fractures or skull deficits, concussion within the last 6 months, unexplained recurring headaches, vagus nerve stimulator, cochlear implant, deep brain stimulator, intracranial/carotid stents, cardiac pacemaker/AICD.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT07041775) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Stroke Treatment Options in Chicago, IL

If you're searching for stroke treatment options in Chicago, IL, this clinical trial (NCT07041775) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all stroke clinical trials near you to find additional studies recruiting in your area.

More Stroke Trials in Chicago, IL

See all stroke clinical trials recruiting in Chicago — not just this study.

Browse Stroke Trials in Chicago →

Browse More Trials by Condition

Stroke TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL